From clinical trials to DNA sequencing and immunotherapy, here are the big changes on the experts’ radar.

Dr. Lanny Kirsch, M.D.

SVP, Translational Medicine Adaptive Biotechnologies

“Being able to treat a patient with more precise and targeted therapies is the most important advance in cancer treatment in the past 50 years.”

Steven Fruchtman, M.D.

Chief Medical Officer, Onconova Therapeutics

“By using genomics, the disease burden can be more accurately followed, with effective therapies employed when the cancer burden is low.”

Naval G. Daver, M.D.

Assistant Professor, Department of Leukemia, MD Anderson Cancer Center

“Diagnostic tests were previously laborious and extremely expensive. But with advances in technology results are often available within days.”

John Pagel, M.D., Ph.D.

Chief, Hematologic Malignancies Program, Swedish Cancer Institute

“We are striving to provide therapy that targets specific mutations relevant to the patient’s unique individual cancer.”